Clinical Trials Browser

Interventional × Glioblastoma × ponatinib × Clear all

NCT02478164 2018-07-24

Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma

Phase 2 Completed

17 enrolled 13 charts

Glioblastoma